Beam Therapeutics BEAM
$20.90 −$0.04 (-0.19%)
Market closed · Nov 20, 8:10 pm ET · Last extended-hours $21.66 +3.65%
Open$20.60
Prev close$20.94
Day range$20.54 – $22.10
Volume3.89M
Market cap$2.16B
P/E (TTM)–
Dividend yield–
Earnings
| Quarter | Report date | Timing | Implied move | Actual move | Versus implied |
|---|---|---|---|---|---|
| 2025/Q4 | 24 Feb 2026 | Pre Market | ±20.9% | +13.98% | Within range |
| 2024/Q3 | 5 Nov 2024 | Pre Market | – | -1.77% | – |
"Implied move" is the size of move the options market was pricing ahead of the report. Move is the stock’s change on the first session after the release.
Fundamentals
Latest reported quarter: Q3, ended Sep 2026
Revenue$307,000.00-96.8% YoY
Operating profit-$141.32M-11.4% YoY
Net profit-$134.41M-19.4% YoY
Diluted EPS-$1.28-16.4% YoY
Free cash flow-$111.96M-29.4% YoY
Operating cash flow-$110.75M
Revenue, last 8 quarters
Net profit, last 8 quarters
Profitability & balance sheet
Operating margin-267.7%
Net margin-73.9%
Return on equity-11.3%
Return on assets-8.4%
Return on invested capital-9.4%
Current ratio13.00
Liabilities / assets24.9%
Cash & investments$1.04B
Total debt$228.23M
Net cash (debt)$815.65M
No comments yet — be the first to weigh in on BEAM.
Sign in to join the discussion.